RADI-11. NRG ONCOLOGY CC001: A PHASE III TRIAL OF HIPPOCAMPAL AVOIDANCE IN ADDITION TO WHOLE-BRAIN RADIOTHERAPY (WBRT) PLUS MEMANTINE TO PRESERVE NEUROCOGNITIVE FUNCTION IN PATIENTS WITH BRAIN METASTASES (BM) Article

Tomé, Wolfgang, Deshmukh, Snehal, Gondi, Vinai et al. (2019). RADI-11. NRG ONCOLOGY CC001: A PHASE III TRIAL OF HIPPOCAMPAL AVOIDANCE IN ADDITION TO WHOLE-BRAIN RADIOTHERAPY (WBRT) PLUS MEMANTINE TO PRESERVE NEUROCOGNITIVE FUNCTION IN PATIENTS WITH BRAIN METASTASES (BM) . 1(Supplement_1), i23-i24. 10.1093/noajnl/vdz014.104

cited authors

  • Tomé, Wolfgang; Deshmukh, Snehal; Gondi, Vinai; Brown, Paul; Wefel, Jeffery; Armstrong, Terri; Bruner, Deborah; Bovi, Joseph; Robinson, Clifford; Khuntia, Deepak; Grosshans, David; Konski, Andre; Roberge, David; Kundapur, Vijayananda; Devisetty, Kiran; Shah, Sunjay; Usuki, Kenneth; Anderson, Bethany Marie; Mehta, Minesh; Kachnic, Lisa

authors

publication date

  • August 12, 2019

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Mental Health
  • Minority Health
  • Neurosciences
  • Patient Safety
  • Radiation Oncology
  • Rare Diseases
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • i23

end page

  • i24

volume

  • 1

issue

  • Supplement_1